B. Besse, L. Havel, S. Peters, S. Marreaud, N. Jha, K. Oselin, E. Esteban González, M. Isla Casado, A. Martínez-Martí, M. Faehling, J.-S. Lee, Y. Luo, S.M. Keller, U. Dafni, M.E. Mauer, R. Stahel, M.E.R. O'Brien, M. Tsuboi, L. Paz-Ares
{"title":"120MO Adjuvant pembrolizumab versus placebo for early-stage NSCLC after resection and optional chemotherapy: Updated results from PEARLS/KEYNOTE-091","authors":"B. Besse, L. Havel, S. Peters, S. Marreaud, N. Jha, K. Oselin, E. Esteban González, M. Isla Casado, A. Martínez-Martí, M. Faehling, J.-S. Lee, Y. Luo, S.M. Keller, U. Dafni, M.E. Mauer, R. Stahel, M.E.R. O'Brien, M. Tsuboi, L. Paz-Ares","doi":"10.1016/j.iotech.2023.100592","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100592","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
